Rx track-and-trace measure advances in US
This article was originally published in SRA
Executive Summary
Legislation intended to better secure the US pharmaceutical supply chain against counterfeit drugs cleared an initial hurdle on 8 May, advancing out of the House Energy & Commerce Health Subcommittee to the full committee, with lawmakers approving the measure by a voice vote1,2.